Treatment of gram-positive peritonitis in peritoneal dialysis patients: Cefazolin or vancomycin?

Peritoneal Dialysis International

Volumn 23, Issue 6, 2003, Pages 599-601

  Lévesque, Renée ^a   Lemiuex, Claude ^a   Laverdière, Michel ^b   Pichette, Vincent ^b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CEFAZOLIN; COAGULASE; GENTAMICIN; METICILLIN; NETILMICIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM ISOLATION; CATHETER INFECTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; GRAM POSITIVE BACTERIUM; HEMODIALYSIS PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT FAILURE;

EID: 0346220086     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080302300616     Document Type: Article

References (10)

1. Keane WF, Alexander SR, Bailie GR. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int 1996; 16:557-73.
2. Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, et al. Adult peritoneal dialysis related peritonitis treatment recommendations: 2000 update [Published erratum appears in Perit Dial Int 2000; 20: 828-9.]. Perit Dial Int 2000; 20:396-411.
3. Sandoe JA, Gokal R, Struthers K. Vancomycin-resistant enterococci and empirical vancomycin for CAPD peritonitis. Perit Dial Int 1997; 17:617-18.
4. Piraino B. Peritonitis as a complication of peritoneal dialysis. J Am Soc Nephrol 1998; 9:1956-64.
5. Vas S, Bargman J, Oreopoulos DG. Treatment in PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics. Perit Dial Int 1997; 17:91-4.
6. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically. 5th ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000: Approved Standard M7-A5.
7. Lai MN, Kao MT, Chen CC, Cheung SY, Shung WK. Intraperitoneal once-daily dose of cefazolin and gentamicin for treating CAPD peritonitis. Perit Dial Int 1997; 17:87-8.
8. Ariano RE, Franczuk C, Fine A, Harding GK, Zelenitsky SA. Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients. Perit Dial Int 2002; 22:335-8.
9. Khairullah Q, Provenzano R, Tayeb J, Ahmad A, Balakrishnan R, Morrison L. Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients. Perit Dial Int 2002; 22: 339-44.
10. Manley HJ, Bailie GR, Asher RD, Eisele G, Frye RF. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1999; 19:65-70.